Stay updated with breaking news from Local Coverage Determination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Renalytix receives U.S. Government approval for kidneyintelX.dkd inclusion in a 10-year contract for early-stage kidney disease testing services at $950 per result. Medicare coverage pending final policy approval.
On February 6, 2024, the US Centers for Medicare & Medicaid Services (CMS) released a set of frequently asked questions (FAQs) related to Medicare Advantage (MA) coverage criteria and...
LONDON and SALT LAKE CITY, Feb. 15, 2024 -- Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease, today...
LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”), an artificial intelligence-enabled...
Shares of ZoomInfo Technologies Inc. (NASDAQ: ZI) rose sharply in today’s pre-market trading as the company reported stronger-than-expected fourth-quarter financial results.